$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex

$omex Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023011378 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q3
Revenue	$288.7K	$286.4K	$358.4K
YoY Change	-3.63%	14.48%	81.89%
Cost Of Revenue
YoY Change
Gross Profit		$286.4K	$358.4K
YoY Change		14.48%	81.89%
Gross Profit Margin		100.0%	100.0%
Selling, General & Admin	$1.878M	$3.804M	$2.214M
YoY Change	-73.08%	-11.26%	-34.28%
% of Gross Profit		1328.0%	617.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$143.6K	$59.88K	$18.18K
YoY Change	5961.05%	2561.33%	786.83%
% of Gross Profit		20.91%	5.07%
Operating Expenses	$1.878M	$3.804M	$2.214M
YoY Change	-73.08%	-11.26%	-34.28%
Operating Profit	-$3.377M	-$3.517M	-$3.720M
YoY Change	-49.41%	-12.86%	17.31%
Interest Expense	$3.809M	-$3.549M	$3.665M
YoY Change	-218.08%	20.37%	-227.83%
% of Operating Profit
Other Income/Expense, Net	$17.74M	$205.4K	-$3.670M
YoY Change	-9422.14%	-1.58%	16474.38%
Pretax Income	$14.36M	-$6.861M	-$7.390M
YoY Change	-242.3%	338.92%	29.97%
Income Tax	-$5.746K	$0.00	$0.00
% Of Pretax Income	-0.04%
Net Earnings	$16.60M	-$4.772M	-$5.455M
YoY Change	-301.7%	-6327.89%	33.53%
Net Earnings / Revenue	5749.32%	-1666.08%	-1522.07%
Basic Earnings Per Share	$0.84	-$0.19	-$0.28
Diluted Earnings Per Share	$0.83	-$0.19	-$0.28
COMMON SHARES
Basic Shares Outstanding	19.59M	19.51M	19.49M
Diluted Shares Outstanding	19.89M		19.48M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$674.4K	$1.443M	$6.783M
YoY Change	-67.98%	-36.55%	91.43%
Cash & Equivalents	$674.4K	$1.443M	$6.800M
Short-Term Investments
Other Short-Term Assets	$1.065M	$947.4K	$481.4K
YoY Change	41.32%	21.99%	123.93%
Inventory
Prepaid Expenses		$722.0K
Receivables	$17.00	$7.515K	$422.7K
Other Receivables	$2.034M	$1.577M	$10.00
Total Short-Term Assets	$3.780M	$3.975M	$7.687M
YoY Change	21.08%	19.72%	91.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.851M	$3.046M	$648.2K
YoY Change	546.64%	535.82%	25.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.676M	$4.405M	$4.147M
YoY Change	31.76%	35.37%	37.96%
Other Assets	$34.30K	$34.30K	$34.30K
YoY Change	-0.01%	0.0%	-17.97%
Total Long-Term Assets	$9.382M	$9.325M	$6.613M
YoY Change	60.51%	66.85%	22.81%
TOTAL ASSETS
Total Short-Term Assets	$3.780M	$3.975M	$7.687M
Total Long-Term Assets	$9.382M	$9.325M	$6.613M
Total Assets	$13.16M	$13.30M	$14.30M
YoY Change	46.78%	49.29%	52.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.439M	$2.286M	$2.569M
YoY Change	-74.66%	25.78%	-6.69%
Accrued Expenses	$32.99M	$40.48M	$37.89M
YoY Change	6.43%	44.54%	28.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.907M	$21.73M	$20.28M
YoY Change	-92.37%	-4.61%	-29.71%
Total Short-Term Liabilities	$36.33M	$64.69M	$60.74M
YoY Change	-41.07%	22.96%	-0.7%
LONG-TERM LIABILITIES
Long-Term Debt	$34.20M	$25.01M	$24.35M
YoY Change	75.55%	35.39%	53.99%
Other Long-Term Liabilities	$78.50K	$129.1K	$186.4K
YoY Change	-71.08%	-59.11%	-48.09%
Total Long-Term Liabilities	$34.28M	$25.14M	$24.54M
YoY Change	73.54%	33.8%	51.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.33M	$64.69M	$60.74M
Total Long-Term Liabilities	$34.28M	$25.14M	$24.54M
Total Liabilities	$70.62M	$89.83M	$85.28M
YoY Change	63.85%	25.81%	100.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$281.6M	-$298.2M	-$293.5M
YoY Change		8.41%
Common Stock	$270.6M	$265.9M	$264.6M
YoY Change		6.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.02M	-$32.35M	-$28.84M
YoY Change
Total Liabilities & Shareholders Equity	$13.16M	$13.28M	$14.34M
YoY Change	46.78%	49.09%	52.59%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	$16.60M	-$4.772M	-$5.455M
YoY Change	-301.7%	-6327.89%	33.53%
Depreciation, Depletion And Amortization	$143.6K	$59.88K	$18.18K
YoY Change	5961.05%	2561.33%	786.83%
Cash From Operating Activities	-$3.488M	-$3.222M	-$3.360M
YoY Change	106.92%	176.08%	158.79%
INVESTING ACTIVITIES
Capital Expenditures	$5.326K	$1.030M	-$4.420K
YoY Change	-284.93%	-34420.0%	100.0%
Acquisitions
YoY Change
Other Investing Activities		-$1.000M
YoY Change		-392.29%
Cash From Investing Activities	-$5.326K	-$2.030M	-$4.420K
YoY Change	84.93%	-698.47%	100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.724M	-87.95K	-388.2K
YoY Change	79.21%	-80.03%	-779.71%
NET CHANGE
Cash From Operating Activities	-3.488M	-3.222M	-3.360M
Cash From Investing Activities	-5.326K	-2.030M	-4.420K
Cash From Financing Activities	2.724M	-87.95K	-388.2K
Net Change In Cash	-769.0K	-5.339M	-3.752M
YoY Change	356.54%	320.98%	201.79%
FREE CASH FLOW
Cash From Operating Activities	-$3.488M	-$3.222M	-$3.360M
Capital Expenditures	$5.326K	$1.030M	-$4.420K
Free Cash Flow	-$3.493M	-$4.251M	-$3.355M
YoY Change	107.59%	265.25%	158.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2015-08-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000798528
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-31895
CY2022	dei	Entity Registrant Name EntityRegistrantName	ODYSSEY MARINE EXPLORATION, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1018684
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	205 S. Hoover Blvd
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33609
CY2022	dei	City Area Code CityAreaCode	813
CY2022	dei	Local Phone Number LocalPhoneNumber	876-1776
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	OMEX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	63700000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19588571
CY2022	dei	Auditor Name AuditorName	Warren Averett, LLC
CY2022	dei	Auditor Firm AuditorFirmId	2226
CY2022	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2022Q4	us-gaap	Cash Cash	1443421
CY2021Q4	us-gaap	Cash Cash	2274751
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	7515
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	268867
CY2022Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	1576717
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	947428
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	776630
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3975081
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3320248
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8137026
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5602915
CY2022Q4	omex	Property Plant And Equipment Subject To Operating Leases PropertyPlantAndEquipmentSubjectToOperatingLeases	300025
CY2021Q4	omex	Property Plant And Equipment Subject To Operating Leases PropertyPlantAndEquipmentSubjectToOperatingLeases	461109
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5390559
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5584881
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3046492
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	479143
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4404717
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3253950
CY2022Q4	omex	Exploration License ExplorationLicense	1821251
CY2021Q4	omex	Exploration License ExplorationLicense	1821251
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34295
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34295
CY2022Q4	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	6260263
CY2021Q4	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	5109496
CY2022Q4	us-gaap	Assets Assets	13281836
CY2021Q4	us-gaap	Assets Assets	8908887
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2285892
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1817445
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	40481204
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	27222337
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	186656
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	163171
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	21732654
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	23405780
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	64686406
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52608733
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25011049
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	18472997
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	129139
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	315795
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	25140188
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	18788792
CY2022Q4	us-gaap	Liabilities Liabilities	89826594
CY2021Q4	us-gaap	Liabilities Liabilities	71397525
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	24984166
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	24984166
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19540310
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19540310
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14309315
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14309315
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1954
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1431
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	265882279
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	249055600
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-298231607
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-275090857
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-32347374
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-26033826
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-44197384
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-36454812
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-76544758
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-62488638
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13281836
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8908887
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1334702
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	921238
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2038332
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8487070
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6321798
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3749912
CY2022	omex	Operations And Research Expense OperationsAndResearchExpense	9891593
CY2021	omex	Operations And Research Expense OperationsAndResearchExpense	9550619
CY2020	omex	Operations And Research Expense OperationsAndResearchExpense	10923819
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	18378663
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	15872417
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	14673731
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-17043961
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-14951179
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-12635399
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	96478
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	4036
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	5121
CY2022	us-gaap	Interest Expense InterestExpense	14086466
CY2021	us-gaap	Interest Expense InterestExpense	10829464
CY2020	us-gaap	Interest Expense InterestExpense	6915535
CY2022	omex	Gain Loss On Cuota Appreciation Rights Extinguishment GainLossOnCuotaAppreciationRightsExtinguishment	315235
CY2021	omex	Gain Loss On Cuota Appreciation Rights Extinguishment GainLossOnCuotaAppreciationRightsExtinguishment	0
CY2020	omex	Gain Loss On Cuota Appreciation Rights Extinguishment GainLossOnCuotaAppreciationRightsExtinguishment	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	374835
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-777484
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	5212902
CY2020	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-732958
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-164608
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4061090
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36214
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13839361
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1176601
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8457070
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-30883322
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16127780
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-21092469
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Profit Loss ProfitLoss	-30883322
CY2021	us-gaap	Profit Loss ProfitLoss	-16127780
CY2020	us-gaap	Profit Loss ProfitLoss	-21092469
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7742572
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6171385
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6280313
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23140750
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-9956395
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14812156
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.34
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.41
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17310915
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13296687
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10538114
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17310915
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13296687
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10538114
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-53297415
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8243383
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	2449322
CY2020	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	6
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	12
CY2020	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	471121
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4095780
CY2020	omex	Adjustments To Additional Paid In Capital Debt Modification Inducement AdjustmentsToAdditionalPaidInCapitalDebtModificationInducement	418987
CY2020	omex	Adjustments To Additional Paid In Capital Subsidiary Equity Issued AdjustmentsToAdditionalPaidInCapitalSubsidiaryEquityIssued	800000
CY2020	us-gaap	Profit Loss ProfitLoss	-21092469
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-57911273
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	2774279
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6500000
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	232175
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1330078
CY2021	omex	Adjustments To Additional Paid In Capital Subsidiary Equity Issued AdjustmentsToAdditionalPaidInCapitalSubsidiaryEquityIssued	713879
CY2021	us-gaap	Profit Loss ProfitLoss	-16127780
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-62488638
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8812964
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2125627
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5888611
CY2022	us-gaap	Profit Loss ProfitLoss	-30883322
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-76544758
CY2022	us-gaap	Profit Loss ProfitLoss	-30883322
CY2021	us-gaap	Profit Loss ProfitLoss	-16127780
CY2020	us-gaap	Profit Loss ProfitLoss	-21092469
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1150767
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	883156
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	870794
CY2022	us-gaap	Depreciation Depreciation	88389
CY2021	us-gaap	Depreciation Depreciation	8821
CY2020	us-gaap	Depreciation Depreciation	9322
CY2022	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	146896
CY2021	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	133993
CY2020	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	52213
CY2022	omex	Amortization Of Loan Prepayment Premium AmortizationOfLoanPrepaymentPremium	300000
CY2021	omex	Amortization Of Loan Prepayment Premium AmortizationOfLoanPrepaymentPremium	0
CY2020	omex	Amortization Of Loan Prepayment Premium AmortizationOfLoanPrepaymentPremium	0
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	295932
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	45171
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-150322
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	61009
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0
CY2020	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	0
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	161084
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	145930
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	132764
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1811551
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1250585
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	420648
CY2022	omex	Debt Instrument Gain Loss On Settlement Of Debt DebtInstrumentGainLossOnSettlementOfDebt	0
CY2021	omex	Debt Instrument Gain Loss On Settlement Of Debt DebtInstrumentGainLossOnSettlementOfDebt	-5212902
CY2020	omex	Debt Instrument Gain Loss On Settlement Of Debt DebtInstrumentGainLossOnSettlementOfDebt	0
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3818750
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2022	us-gaap	Accretion Expense AccretionExpense	0
CY2021	us-gaap	Accretion Expense AccretionExpense	0
CY2020	us-gaap	Accretion Expense AccretionExpense	121398
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	374835
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-777484
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	342125
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0
CY2022	omex	Beneficial Conversion Feature On Convertible Debt Interest Expense BeneficialConversionFeatureOnConvertibleDebtInterestExpense	0
CY2021	omex	Beneficial Conversion Feature On Convertible Debt Interest Expense BeneficialConversionFeatureOnConvertibleDebtInterestExpense	232175
CY2020	omex	Beneficial Conversion Feature On Convertible Debt Interest Expense BeneficialConversionFeatureOnConvertibleDebtInterestExpense	0
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-732958
CY2022	omex	Payment Of Operating Lease Liability PaymentOfOperatingLeaseLiability	163171
CY2021	omex	Payment Of Operating Lease Liability PaymentOfOperatingLeaseLiability	142080
CY2020	omex	Payment Of Operating Lease Liability PaymentOfOperatingLeaseLiability	123152
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	241707
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	108610
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-261336
CY2022	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	12649
CY2021	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	0
CY2020	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	0
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	170798
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	181725
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-399082
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5974387
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6292180
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4563544
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14651375
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	13658052
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5583783
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9253809
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5425056
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9182205
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	342125
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1346424
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19137
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1000000
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2346424
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	322988
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2200000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1375511
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3620977
CY2022	omex	Proceeds From Sale Of Equity Of Subsidiary ProceedsFromSaleOfEquityOfSubsidiary	0
CY2021	omex	Proceeds From Sale Of Equity Of Subsidiary ProceedsFromSaleOfEquityOfSubsidiary	713879
CY2020	omex	Proceeds From Sale Of Equity Of Subsidiary ProceedsFromSaleOfEquityOfSubsidiary	800000
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	5546736
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	355273
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	286198
CY2022	omex	Repurchase Of Stockbased Awards Withheld For Payment Of Withholding Tax Requirements RepurchaseOfStockbasedAwardsWithheldForPaymentOfWithholdingTaxRequirements	585936
CY2021	omex	Repurchase Of Stockbased Awards Withheld For Payment Of Withholding Tax Requirements RepurchaseOfStockbasedAwardsWithheldForPaymentOfWithholdingTaxRequirements	20503
CY2020	omex	Repurchase Of Stockbased Awards Withheld For Payment Of Withholding Tax Requirements RepurchaseOfStockbasedAwardsWithheldForPaymentOfWithholdingTaxRequirements	228116
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1810800
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	89642
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16512375
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11315000
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	500000
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10768903
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1213614
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15132021
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-831330
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3888454
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5949816
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2274751
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6163205
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213389
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1443421
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2274751
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6163205
CY2022	us-gaap	Interest Paid Net InterestPaidNet	222731
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1275269
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	0
CY2022	us-gaap	Stock Issued1 StockIssued1	403007
CY2021	us-gaap	Stock Issued1 StockIssued1	100000
CY2020	us-gaap	Stock Issued1 StockIssued1	278602
CY2022	omex	Accrued Expenses Converted To Equity AccruedExpensesConvertedToEquity	497000
CY2021	omex	Accrued Expenses Converted To Equity AccruedExpensesConvertedToEquity	0
CY2020	omex	Accrued Expenses Converted To Equity AccruedExpensesConvertedToEquity	0
CY2022	omex	Accounts Payable Settled With Equity Value AccountsPayableSettledWithEquityValue	0
CY2021	omex	Accounts Payable Settled With Equity Value AccountsPayableSettledWithEquityValue	0
CY2020	omex	Accounts Payable Settled With Equity Value AccountsPayableSettledWithEquityValue	50000
CY2022	omex	Gain On Debt Forgiveness GainOnDebtForgiveness	0
CY2021	omex	Gain On Debt Forgiveness GainOnDebtForgiveness	370400
CY2020	omex	Gain On Debt Forgiveness GainOnDebtForgiveness	0
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1400000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0
CY2022	omex	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	70398
CY2021	omex	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	0
CY2020	omex	Capital Expenditures Included In Accounts Payable CapitalExpendituresIncludedInAccountsPayable	0
CY2022	omex	Conversion Of Accounts Receivable To Note Receivable ConversionOfAccountsReceivableToNoteReceivable	503059
CY2021	omex	Conversion Of Accounts Receivable To Note Receivable ConversionOfAccountsReceivableToNoteReceivable	0
CY2020	omex	Conversion Of Accounts Receivable To Note Receivable ConversionOfAccountsReceivableToNoteReceivable	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3117731
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	916158
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1112293
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23140750
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:9.067%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Management used estimates and assumptions in preparing these consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</span></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:9.067%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Certain reclassifications have been made to the 2021 consolidated financial statements in order to conform to the classifications used in 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. The reclassifications had no impact to operations or working capital.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p>
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-9956395
CY2022	omex	Short Term Investments Maturity Period ShortTermInvestmentsMaturityPeriod	P3M
CY2022	omex	Exploration License Impairments ExplorationLicenseImpairments	0
CY2021	omex	Exploration License Impairments ExplorationLicenseImpairments	0
CY2020	omex	Exploration License Impairments ExplorationLicenseImpairments	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17310915
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13296687
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10538114
CY2022	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	4.22
CY2021	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	6.50
CY2020	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	5.06
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14812156
CY2022	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-23140750
CY2021	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-9956395
CY2020	omex	Net Income Loss Available To Common Stockholders Basic And Diluted NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted	-14812156
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17310915
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13296687
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10538114
CY2022	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	17310915
CY2021	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	13296687
CY2020	omex	Shares Used In Computation For Earning Per Share Basic SharesUsedInComputationForEarningPerShareBasic	10538114
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.34
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.41
CY2022Q4	us-gaap	Loans Receivable With Variable Rates Of Interest1 LoansReceivableWithVariableRatesOfInterest1	0
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7515
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	268867
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1576717
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0
CY2022Q4	us-gaap	Loans Payable LoansPayable	46743703
CY2021Q4	us-gaap	Loans Payable LoansPayable	41878777
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	484009
CY2022Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.12
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	722025
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	732562
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	225403
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	44068
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	947428
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	776630
CY2022Q4	omex	Property Plant And Equipment Gross Including Right Of Use Asset PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset	8437051
CY2021Q4	omex	Property Plant And Equipment Gross Including Right Of Use Asset PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset	6064024
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5390559
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5584881
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3046492
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	479143
CY2022Q4	omex	Collateral Asset Carrying Value CollateralAssetCarryingValue	0
CY2022	us-gaap	Debt Conversion Description DebtConversionDescription	Anytime from 30 days after the maturity date, 37N had the option to convert all or a portion of the outstanding amount of the indebtedness into conversion shares equal to the quotient obtained by dividing (A) 125% of the amount of the indebtedness, by (B) the lower of $5.94 and 70% of the 10-day VWAP.
CY2022	omex	Percentage Of Shares Outstanding Post Conversion PercentageOfSharesOutstandingPostConversion	0.199
CY2022	omex	Percentage Of Outstanding Voting Securities PercentageOfOutstandingVotingSecurities	0.199
CY2022	omex	Percentage Of Payment Of Unpaid Principal Amount PercentageOfPaymentOfUnpaidPrincipalAmount	1.10
CY2022Q3	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	From the maturity date to 29 days after the maturity date (July 24, 2022), we were permitted to prepay all (but not less than) an amount equal to 115% of the unpaid amount of the indebtedness.
CY2022Q3	omex	Percentage Of Payment Of Unpaid Principal Amount PercentageOfPaymentOfUnpaidPrincipalAmount	1.15
CY2022Q3	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	Anytime, after the 30th day after the maturity date (July 25, 2022), we were permitted to prepay all (but not less than) an amount equal to 125% of the unpaid amount of the indebtedness
CY2022Q3	omex	Percentage Of Payment Of Unpaid Principal Amount PercentageOfPaymentOfUnpaidPrincipalAmount	1.25
CY2022	omex	Prepayment Notice Prior To Repayment Period PrepaymentNoticePriorToRepaymentPeriod	P10D
CY2022	omex	Exercise Notice Period ExerciseNoticePeriod	P10D
CY2022	omex	Percentage Of Number Of Shares Issued After Exercise Notice PercentageOfNumberOfSharesIssuedAfterExerciseNotice	0.199
CY2022	omex	Percentage Of Payment Of Unpaid Principal Amount After Exercise Notice PercentageOfPaymentOfUnpaidPrincipalAmountAfterExerciseNotice	1.30
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2200000
CY2022	omex	Percentage Of Face Value Of Note PercentageOfFaceValueOfNote	1.10
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25011049
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	354187
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1655761
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	470546
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1475522
CY2022Q4	omex	Earnest Money Deposit EarnestMoneyDeposit	657331
CY2021Q4	omex	Earnest Money Deposit EarnestMoneyDeposit	450000
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	35131587
CY2021Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	21875753
CY2022Q4	omex	Accrued Exploration License Fees AccruedExplorationLicenseFees	3867553
CY2021Q4	omex	Accrued Exploration License Fees AccruedExplorationLicenseFees	1765301
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40481204
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27222337
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	238651
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.95
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4939515
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4939515
CY2022Q3	omex	Offering Fees Withheld To Cover Offering Costs OfferingFeesWithheldToCoverOfferingCosts	1800000
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.35
CY2022Q3	omex	Purchase Price Of Warrant PurchasePriceOfWarrant	3.35
CY2022Q3	omex	Class Of Warrant Or Right Expiration Beginning Date ClassOfWarrantOrRightExpirationBeginningDate	2022-12-10
CY2022Q3	omex	Class Of Warrant Or Right Expiration Date ClassOfWarrantOrRightExpirationDate	2027-06-10
CY2020Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2553314
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1901985
CY2020Q3	omex	Offering Fees Withheld To Cover Offering Costs OfferingFeesWithheldToCoverOfferingCosts	300000
CY2020Q3	omex	Offering Fee Included In Offering Expenses OfferingFeeIncludedInOfferingExpenses	200000
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.6
CY2020Q3	omex	Purchase Price Of Warrant PurchasePriceOfWarrant	4.543
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.75
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4939515
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.35
CY2022Q3	omex	Class Of Warrant Or Right Expiration Beginning Date ClassOfWarrantOrRightExpirationBeginningDate	2022-12-10
CY2022Q3	omex	Class Of Warrant Or Right Expiration Date ClassOfWarrantOrRightExpirationDate	2027-06-10
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1901985
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.75
CY2022	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	20
CY2022	omex	Number Of Stock Incentive Plans NumberOfStockIncentivePlans	3
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1811551
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1250585
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	420648
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	238651
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.95
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	238651
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.95
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	621348
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.60
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	859999
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y29D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	238651
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.95
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	238651
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.95
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	602591
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.49
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M15D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	127605
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	55392
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	98129
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	202587
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	55392
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	98129
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1412087
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	628767
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y21D
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	859999
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y29D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.02
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8392466
CY2022	omex	Gain Loss On Cuota Appreciation Rights Extinguishment GainLossOnCuotaAppreciationRightsExtinguishment	315235
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022Q4	omex	Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards	83383006
CY2021Q4	omex	Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards	72201754
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	5514
CY2021Q4	omex	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpenses	363149
CY2022Q4	omex	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	6033
CY2021Q4	omex	Deferred Tax Assets Start Up Costs DeferredTaxAssetsStartUpCosts	5664
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	240231
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	259667
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1806546
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1429488
CY2022Q4	omex	Deferred Tax Assets Debt Extinguishment DeferredTaxAssetsDebtExtinguishment	61945
CY2021Q4	omex	Deferred Tax Assets Debt Extinguishment DeferredTaxAssetsDebtExtinguishment	58161
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85268067
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	74138667
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	229694
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	184730
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	50174
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10434
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	179520
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	174296
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	229694
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	184730
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85268067
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	74138667
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11129400
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6485498
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3386834
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4429419
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1698583
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-570116
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-940302
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	78422
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-56839
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	150238
CY2022	omex	Income Tax Reconciliation Sub Part F Income IncomeTaxReconciliationSubPartFIncome	33040
CY2021	omex	Income Tax Reconciliation Sub Part F Income IncomeTaxReconciliationSubPartFIncome	735229
CY2020	omex	Income Tax Reconciliation Sub Part F Income IncomeTaxReconciliationSubPartFIncome	345006
CY2021	omex	Income Tax Reconciliation Debt Extinguishment IncomeTaxReconciliationDebtExtinguishment	0
CY2020	omex	Income Tax Reconciliation Debt Extinguishment IncomeTaxReconciliationDebtExtinguishment	91266
CY2021	omex	Income Tax Reconciliation Litigation Funding IncomeTaxReconciliationLitigationFunding	0
CY2020	omex	Income Tax Reconciliation Litigation Funding IncomeTaxReconciliationLitigationFunding	2482252
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11480322
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6229371
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4815784
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3407703
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2950811
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2514825
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4939515
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4939515
CY2022Q2	omex	Offering Fees Withheld To Cover Offering Costs OfferingFeesWithheldToCoverOfferingCosts	1800000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1443421
CY2022Q4	omex	Working Capital Deficit WorkingCapitalDeficit	60700000
CY2022Q4	us-gaap	Assets Assets	13300000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1443421
CY2022Q4	omex	Percentage Of Annual Rent Accretion In Operating Lease PercentageOfAnnualRentAccretionInOperatingLease	0.03
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	218000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	216000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	194000
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	299606
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	390278
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	358409
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	286409
CY2022Q1	us-gaap	Gross Profit GrossProfit	299606
CY2022Q2	us-gaap	Gross Profit GrossProfit	390278
CY2022Q3	us-gaap	Gross Profit GrossProfit	358409
CY2022Q4	us-gaap	Gross Profit GrossProfit	286409
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-8230229
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4683485
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5455229
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-4771807
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	291676
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	182334
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	197051
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	250177
CY2021Q1	us-gaap	Gross Profit GrossProfit	291676
CY2021Q2	us-gaap	Gross Profit GrossProfit	182334
CY2021Q3	us-gaap	Gross Profit GrossProfit	197051
CY2021Q4	us-gaap	Gross Profit GrossProfit	250177
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-3720218
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2227499
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4085297
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	76619
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02

Files In Submission

Name	View Source	Status
0000950170-23-011378-index-headers.html	Edgar Link	pending
0000950170-23-011378-index.html	Edgar Link	pending
0000950170-23-011378.txt	Edgar Link	pending
0000950170-23-011378-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img210241557_0.jpg	Edgar Link	pending
img210241557_1.jpg	Edgar Link	pending
img211165078_0.jpg	Edgar Link	pending
img211165078_1.jpg	Edgar Link	pending
img259135865_0.jpg	Edgar Link	pending
img259135865_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
omex-20221231.htm	Edgar Link	pending
omex-20221231.xsd	Edgar Link	pending
omex-ex21_1.htm	Edgar Link	pending
omex-ex23_1.htm	Edgar Link	pending
omex-ex23_2.htm	Edgar Link	pending
omex-ex31_1.htm	Edgar Link	pending
omex-ex31_2.htm	Edgar Link	pending
omex-ex32_1.htm	Edgar Link	pending
omex-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
omex-20221231_cal.xml	Edgar Link	unprocessable
omex-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
omex-20221231_pre.xml	Edgar Link	unprocessable
omex-20221231_lab.xml	Edgar Link	unprocessable
omex-20221231_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex

2023 Q1 Form 10-K Financial Statement

#000095017023011378 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMEX ODYSSEY MARINE EXPLORATION INC Stock $omex

2023 Q1 Form 10-K Financial Statement

#000095017023011378 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMEX
ODYSSEY MARINE EXPLORATION INC Stock $omex